Add Tribune As Your Trusted Source
TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My Money
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill ViewBenchmark
Don't Miss
Advertisement

WHO suspends Covaxin supply via UN agencies

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

New Delhi, April 3

Advertisement

The World Health Organisation today said it had suspended the supply of Covaxin, manufactured by India-based Bharat Biotech, through procurement agencies of the United Nations and had asked countries already in receipt of the shot to “take action as appropriate”.

Advertisement

The WHO did not however detail “appropriate action”.

The development implies interruption in Covaxin supply with the production for export suspended for the time being.

In a statement, the global health body said the suspension followed outcomes of its inspection of Bharat Biotech facilities in India as part of the WHO post-emergency use authorisation approval processes. The inspection was held between March 14 and 22.

Advertisement

Bharat Biotech said those who had received Covaxin should not worry as their vaccine certificates were still valid as there was no impact on the efficacy and safety of the vaccine. —

Advertisement
Show comments
Advertisement